Skip to main content
. 2024 Nov 5;18:313–326. doi: 10.2147/BTT.S489363

Figure 3.

Figure 3

CT scan results of the changes for target lesions in the lung site of one patient with advanced non-small cell lung cancer before and after the administration of anlotinib plus pembrolizumab.